Epilepsy Devices Market Share

Epilepsy Devices Market Share Analysis

The market is poised for significant growth due to the increasing occurrence of neurological disorders such as Parkinson’s, Alzheimer’s, depression, and essential tremors. In 2015, Alzheimer's Research UK reported that more than 46.8 million people worldwide had dementia, and this number was anticipated to reach 50 million in 2017. Additionally, the projection suggested a doubling of this figure every 20 years, reaching 75 million by 2030 and 131.5 million by 2050. According to a research paper published by the National Center for Biotechnology Information in 2017, the incident rate of seizures in Alzheimer's Disease is consistently rising in the elderly population. The likelihood of Alzheimer’s patients experiencing epilepsy was found to be 80%, and this number could increase in the future. The significant prevalence of neurological disorders in the population and the increasing healthcare expenditure on epilepsy contribute to the growth of the epilepsy devices market.

The market is expected to experience profitable growth due to the rise in neurological disorders such as Parkinson’s, Alzheimer’s, depression, and essential tremors. In 2015, Alzheimer's Research UK reported that over 46.8 million people worldwide were affected by dementia, and it was expected to reach 50 million patients by 2017. Furthermore, this number was projected to double every 20 years, reaching 75 million by 2030 and 131.5 million by 2050. Additionally, a research paper published by the National Center for Biotechnology Information in 2017 indicated a continuous increase in the incidence rate of seizures in Alzheimer's Disease among the elderly population. The chances of Alzheimer’s patients experiencing epilepsy were found to be 80%, and this number is anticipated to increase in the future. The widespread prevalence of neurological disorders in the population and the rising healthcare expenditure on epilepsy are key factors driving the growth of the epilepsy devices market.

The market is anticipated to witness profitable growth, driven by the increasing occurrence of neurological disorders such as Parkinson’s, Alzheimer’s, depression, and essential tremors. In 2015, Alzheimer's Research UK reported that over 46.8 million people worldwide were affected by dementia, and it was expected to reach 50 million patients by 2017. Moreover, this number was projected to double every 20 years, reaching 75 million by 2030 and 131.5 million by 2050. Additionally, a research paper published by the National Center for Biotechnology Information in 2017 highlighted a continuous increase in the incidence rate of seizures in Alzheimer's Disease among the elderly population. The likelihood of Alzheimer’s patients experiencing epilepsy was found to be 80%, and this number is expected to increase in the future. The widespread prevalence of neurological disorders in the population and the increasing healthcare expenditure on epilepsy contribute significantly to the growth of the epilepsy devices market.